Alnylam Pharmaceuticals, Inc. (ALNY) Technical Analysis & Indicators
Alnylam Pharmaceuticals, Inc. (ALNY) — Price $165.00 (closing price, October 30, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Alnylam Pharmaceuticals, Inc. (ALNY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic infectious diseases, and central nervous system (CNS) and ocular disorders.